Skip to content

Clinical trials

Phase 1/2 trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Country / region: Singapore Clear all

151 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20054
20067
20072
20085
20098
20106
20128
20133
20147
20159
20165
20176
20186
20199
20209
20219
202215
20237
20246
202510
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Recruiting32
Terminated25
Unknown status20
Active, not recruiting18
Withdrawn3
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National University Hospital, Singapore28
Novartis Pharmaceuticals21
Singapore General Hospital9
Bristol-Myers Squibb5
Alachua Government Services, Inc.3
Alentis Therapeutics AG3
Hoffmann-La Roche3
Merck Sharp & Dohme LLC3
National Cancer Centre, Singapore3
Pfizer3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung23
Breast Neoplasms17
Carcinoma, Hepatocellular15
Neoplasm Metastasis12
Neoplasms11
Colorectal Neoplasms8
Head and Neck Neoplasms7
Lung Neoplasms7
Myelodysplastic Syndromes7
Squamous Cell Carcinoma of Head and Neck7

Trials

Showing 26 to 50 of 151. Each trial links to its page on Pharma Observatory.

51 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.